Despite the availability of an effective treatment at numerous hospitals across the United States, a significant barrier prevents the majority of sickle cell patients from accessing it. New findings indicate that merely 3% of individuals suffering from the disease undergo red blood cell exchange procedures.
The treatment in question, known as red blood cell exchange, involves removing a patient’s damaged red blood cells. The remaining plasma, platelets, and white blood cells are then mixed with healthy red blood cells from a donor before being returned to the patient’s body.
Researchers emphasize that various factors are blocking sufferers from receiving this widely accessible and proven therapy, highlighting a critical gap in standard care for sickle cell disease.
We need policy changes immediately. Why is effective therapy withheld from those who need it most?
My cousin missed out on this due to insurance denials. The barrier isn’t availability, it’s access and bureaucracy.
Three percent is shocking. This highlights a severe disparity in how sickle cell patients are treated versus other conditions.